AACR shared a post on LinkedIn:
“AstraZeneca is one of the industry partners supporting the AACR Clinical Oncology Research (CORE) Training Fellowship. This fellowship provides $100,000 over one year for clinical research fellows to train in early- and late-stage clinical development including, but not limited to, antibody-drug conjugates, immunotherapy, and cell therapy. Apply by May 31. ”
Read further.
Source: AACR/LinkedIn